Jungthirapanich Jaakchai, Srithipsukho Pasakorn, Khositseth Sookkasem, Techasatid Wilaiporn
Department of Pediatrics, Thammasat University, Pathumthani, Thailand.
J Med Assoc Thai. 2010 Dec;93 Suppl 7:S241-5.
Acute renal failure (ARF) in a newborn is a common problem. Fractional excretion of sodium (FENa) has been used to distinguish between the two main causes of ARF, prerenal failure and acute tubular necrosis (ATN). However, the clinical usefulness of FENa could be limited by furosemide diuretic that are commonly prescribed inARF patients. In contrast, urea is not reabsorbed significantly in the distal nephron, thus the fractional excretion of urea (FE UN) should not be affected by furosemide.
To test the hypothesis that FE UN is not effected by furosemide and useful in differentiating between prerenal failure and ATN.
Neonates admitted to the Department of Pediatrics, Thammasat University Hospital from August 2007-May 2009 were studies prospectively for ARF which is defined as urine output < 0.5 ml/kg/hr after the 1st day and serum creatinine > 1.5 mg/dl with normal maternal renal function. FENa and FEUN were performed on the initial time of diagnosis and were repeated on two consecutive days.
Neonates with ARF were classified as prerenal failure (n=38) and ATN (n=5). The prerenal failure neonates were divided into two groups: those prerenal failure without furosemide (n=27), those prerenal failure with furosemide (n=11). The FENa at the initial time of diagnosis and the two consecutive days in prerenal failure neonates (0.33 +/- 0.57, 10.1 +/- 2.73, 0.8 +/- 1.32%, respectively) were lower than ATN neonates (4.74 +/- 6.12, 5.05 +/- 4.03, 3.98 +/- 2.47%, respectively) significantly. Both FENa and FE UN were no statistical difference between the two prerenal failure groups and ATN neonates.
A FE Na in prerenal failure is significantly lower than ATN. A FE UN has no benefit in distinguishing between prerenal failure and ATN. Furosemide has no effect on both FENa and FE UN.
新生儿急性肾衰竭(ARF)是一个常见问题。钠排泄分数(FENa)已被用于区分ARF的两个主要病因,即肾前性肾衰竭和急性肾小管坏死(ATN)。然而,FENa的临床实用性可能会受到ARF患者常用的呋塞米利尿剂的限制。相比之下,尿素在远端肾单位中不会被显著重吸收,因此尿素排泄分数(FE UN)不应受呋塞米影响。
验证FE UN不受呋塞米影响且有助于区分肾前性肾衰竭和ATN这一假设。
对2007年8月至2009年5月在泰国国立法政大学医院儿科住院的新生儿进行前瞻性研究,以确定ARF,ARF定义为出生后第1天尿量<0.5 ml/kg/hr且血清肌酐>1.5 mg/dl,同时母亲肾功能正常。在诊断初期测定FENa和FEUN,并连续两天重复测定。
患有ARF的新生儿分为肾前性肾衰竭组(n = 38)和ATN组(n = 5)。肾前性肾衰竭新生儿又分为两组:未使用呋塞米的肾前性肾衰竭组(n = 27)和使用呋塞米的肾前性肾衰竭组(n = 11)。肾前性肾衰竭新生儿在诊断初期及连续两天的FENa(分别为0.33±0.57、10.1±2.73、0.8±1.32%)显著低于ATN新生儿(分别为4.74±6.12、5.05±4.03、3.98±2.47%)。两个肾前性肾衰竭组与ATN新生儿之间的FENa和FE UN均无统计学差异。
肾前性肾衰竭时的FE Na显著低于ATN。FE UN对区分肾前性肾衰竭和ATN无帮助。呋塞米对FENa和FE UN均无影响。